Abstract
Concentrated suspensions of washed Mycoplasma neurolyticum produce rolling disease in mice and rats, with neurological manifestations and pathological lesions similar to those seen with the exotoxin of this organism. Pretreatment of animals with tetracycline protects completely against the toxic effects of washed suspensions of mycoplasmas, while tetracycline affords no protection against the exotoxin. Freeze-thawing disruption of mycoplasma suspensions eliminates their neurotoxicity, while the same treatment does not affect exotoxin. The toxicity of intact organisms is not affected by exposure to the sedimentable component of brain, nor to ganglioside. These observations are interpreted to indicate that the neurotoxicity of living mycoplasmas must be due to their production of toxin after they have been injected into the animal. Resting mycoplasmas, suspended in Ringer's solution in dialysis sacs submerged in PPLO broth) produce considerable amounts of toxin within 15 min of incubation at 37°C. Toxin is also produced, although in somewhat less amount, by washed organisms suspended in phosphate buffer containing glucose. The formation of toxin is prevented by the presence of puromycin, but not by the aminonucleoside analogue of puromycin, indicating that active protein synthesis is involved in the elaboration of toxin. The similarities between the neurotoxicity of the intact organisms of M. neurolyticum and Mycoplasma gallisepticum are discussed.
Full Text
The Full Text of this article is available as a PDF (509.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- David J. R. Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis. J Exp Med. 1965 Dec 1;122(6):1125–1134. doi: 10.1084/jem.122.6.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NATHANS D., NEIDLE A. Structural requirements for puromycin inhibition of protein synthesis. Nature. 1963 Mar 16;197:1076–1077. doi: 10.1038/1971076a0. [DOI] [PubMed] [Google Scholar]
- Sabin A. B. ISOLATION OF A FILTRABLE, TRANSMISSIBLE AGENT WITH "NEUROLYTI" PROPERTIES FROM TOXOPLASMA-INFECTED TISSUES. Science. 1938 Aug 26;88(2278):189–191. doi: 10.1126/science.88.2278.189. [DOI] [PubMed] [Google Scholar]
- TULLY J. G. PRODUCTION AND BIOLOGICAL CHARACTERISTICS OF AN EXTRACELLULAR NEUROTOXIN FROM MYCOPLASMA NEUROLYTICUM. J Bacteriol. 1964 Aug;88:381–388. doi: 10.1128/jb.88.2.381-388.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas L., Aleu F., Bitensky M. W., Davidson M., Gesner B. Studies of PPLO infection. II. The neurotoxin of Mycoplasma neurolyticum. J Exp Med. 1966 Dec 1;124(6):1067–1082. doi: 10.1084/jem.124.6.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]